RedcarePharmacyN.V./ NL0012044747 /
30/05/2024 07:57:13 | Var. -0.5000 | Volume | Denaro09:46:46 | Lettera09:46:46 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
113.4000EUR | -0.44% | - Fatturato: - |
114.0000Quantità in denaro: 140 | 114.4000Quantità in lettera: 140 | 2.19 bill.EUR | - | - |
GlobeNewswire
09:42
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire
09:01
Persistent Systems Selects Zscaler to Launch Technology Modernization and Renewable Energy Initiativ...
GlobeNewswire
09:00
Curium Announces First Commercial Doses in France of Pylclari® – an Innovative 18F-Psma Pet Tracer I...
GlobeNewswire
09:00
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area